https://scienztech.org/index.php/ijddn <p><strong>International Journal of Drug Delivery and Nanotechnology (ISSN: 2455-2747) </strong>is an Open-access international peer- reviewed quarterly journal that covers all aspects of Drug Delivery system and nanotechnology. The main focus is to bring into lime-light the various aspects of drug product development, formulation and delivery of pharmaceuticals and diagnostic agents. This includes nanoscale pharmaceutics; tools to understand nanoscale pharmaceutical processes in drug discovery and development; design and development of nanoformulations and nanoscale drug delivery systems and their regulatory aspects . The journal has been developed to create a new forum for scientific publications at the interface of nanotechnology and novel drug delivery systems. IJDDN publishes original rapid communications, full research papers and timely state-of-the-art reviews encompassing fundamental and applied research in nanomaterials for drug delivery, nanopharmaceutics, nanomedicine, nanodiagnostics, nanobiotechnology and nanotoxicology of drug delivery carriers. Rapid communications on new findings with breakthrough results will be considered for accelerated publication.</p> en-US International Journal of Drug Delivery and Nanotechnology 2455-2747 https://scienztech.org/index.php/ijddn/article/view/1529 <p>Cancer remains one of the most significant global health challenges, consistently ranking as the second leading cause of death worldwide. Each year, millions of new cases and fatalities are reported, emphasizing the urgent need for innovative approaches to diagnosis and treatment. In the field of oncology, personalised medicine has emerged as a groundbreaking paradigm, revolutionising cancer care by tailoring therapies to the unique genetic, molecular, and environmental profiles of individual patients.This review highlights the latest advancements in personalised cancer treatments, particularly focusing on targeted therapies, biomarker discovery, and the integration of genetic sequencing. These innovations are not only transforming cancer care but also paving the way for more precise and effective interventions. The use of genomic data in clinical practice is enabling the development of novel targeted drugs and immunotherapies, which hold the potential to improve therapeutic outcomes significantly.However, the implementation of personalised medicine comes with its own set of challenges. Financial constraints, ethical considerations, and logistical barriers remain critical issues that need to be addressed for wider accessibility. Despite these obstacles, personalised medicine offers immense promise in enhancing cancer screening, prognosis, and prevention. By leveraging advancements in genomics, bioinformatics, and molecular biology, this approach continues to reshape oncology, bringing hope to millions of patients worldwide.</p> Priyadharshini K.K Laxmipriya G Copyright (c) 2024 International Journal of Drug Delivery and Nanotechnology 2024-10-10 2024-10-10 10 4 1 15